McKesson Europe AG
Celesio AG: Changes in management of Celesio AG
Celesio AG / Key word(s): Change of Personnel Changes in management of Celesio AG Stuttgart, 22 May 2014. The Supervisory Board of Celesio AG today appointed Marc Owen, to date President of McKesson Specialty Health and member of the McKesson Operating Team, and Alain Vachon, to date Senior Vice President and Chief Financial Officer of McKesson U.S. Pharmaceutical, as new members of the Management Board of Celesio AG with effect from 16 July 2014. Marc Owen will take over the position of Chairman of the Management Board and Alain Vachon will take over the position of Chief Financial Officer. The current speaker of the Management Board and Chief Financial Officer Dr. Marion Helmes has by mutual agreement with the Supervisory Board resigned from her office and terminated her engagement with the Company with effect as of the end of 15 July 2014. The Chief Operating Officer Martin Fisher has by mutual agreement with the Supervisory Board also resigned from his office with effect as of the end of 22 May 2014. Dr. Marion Helmes will additionally take over the position of interim Chief Operating Officer until and including 15 July 2014. The Management Board and the Supervisory Board of Celesio AG today further resolved to enter into the domination and profit and loss transfer agreement with Dragonfly GmbH & Co. KGaA, a 100% indirect subsidiary of McKesson Corporation in line with the terms previously announced (see also ad hoc announcement of Celesio AG of 14 May 2014). The Agreement is expected to be executed by both parties today and will be presented to the Annual General Meeting of Celesio AG for approval on 15 July 2014.
End of Corporate News 22.05.2014 Dissemination of a Corporate News, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
Language: | English | |
Company: | Celesio AG | |
Neckartalstr. 155 | ||
70376 Stuttgart | ||
Germany | ||
Phone: | +49 (0)711 5001-735 | |
Fax: | +49 (0)711 5001-740 | |
E-mail: | investor@celesio.com | |
Internet: | www.celesio.com | |
ISIN: | DE000CLS1001, DE000CLS1043 | |
WKN: | CLS100, CLS104 | |
Indices: | MDAX | |
Listed: | Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime Standard), München, Stuttgart; Freiverkehr in Hamburg, Hannover; Terminbörse EUREX | |
End of News | DGAP News-Service |
270044 22.05.2014 |